Veliki bilateralni angiomiolipomi otkriveni posle masivne retroperitonealne hemoragije

  • Sladjana Petrović Center for Radiology, Clinical Center, Faculty of Medicine, University of Niš, Serbia
  • Aleksandar Tasić Center for Radiology, Clinical Center, Faculty of Medicine, University of Niš, Serbia
  • Dragan Mihailović Institut for Pathology, Clinical Center, Faculty of Medicine, University of Niš, Serbia
  • Nikola Živković Institut for Pathology, Clinical Center, Faculty of Medicine, University of Niš, Serbia
  • Marija Vitanović Department of Radiology, General Hospital, Pirot, Serbia
  • Dragan Stojanov Center for Radiology, Clinical Center, Faculty of Medicine, University of Niš, Serbia
DOI: https://doi.org/10.2298/3172
Ključne reči: kidney neoplasms||, ||bubreg, neoplazme, angiomyolipoma||, ||angiomiolipom, diagnosis, differential||, ||dijagnoza, diferencijalna,

Sažetak


Uvod. Angiomiolipomi (AML) su benigni tumori, izgrađeni od masnog i glatkomišićnog tkiva i krvnih sudova u različitim odnosima. Ovi tumori češći su  u ženskoj populaciji. Prikaz bolesnika. Predstavljen je bolesnik, star 61 godinu, sa spontanom rupturom AML. Kompjuterizovanom tomografijom uočena je izmenjena morfologija oba bubrega. U levom bubregu viđene su multiple lezije u masnom tkivu sa dilatiranim krvnim sudovima. Na desnom bubregu uočena je velika heterogena masa koja je ispunjavala desni retroperitonealni prostor, sa masivnim krvarenjem, aktivnom ekstrvazacijom, kompresijom donje šuplje vene i intraperitonealna kolekcija. Posle radikalne nefrektomije, histološkom analizom utvrđeno je da tumor čini nejednak odnos masnog i glatko-mišićnog tkiva i krvnih sudova. Mali bubrežni adenom bio je uzgredan nalaz. Zaključak. Pravo poreklo ovih AML nije u potpunosti razjašnjeno, ali često se svrstavaju u hamartome. To su uglavnom benigni tumori, dok su epiteloidni angiomiolipomi varijanta koja se sreće kod oko 3% slučajeva, mogu da imaju agresivni tok.

Reference

Steiner MS, Goldman SM, Fishman EK, Marshall FF. The natural history of renal angiomyolipoma. J Urol 1993; 150(6): 1782−6.

Oesterling JE, Fishman EK, Goldman SM, Marshall FF. The man-agement of renal angiomyolipoma. J Urol 1986; 135(6): 1121−4.

Hanna RM, Dahniya MH, Al-Marzouk N, Grexa E. Extrarenal angiomyolipomas of the perinephric space in tuberose sclero-sis. Australas Radiol 1997; 41(4): 339−41.

Nelson CP, Sanda MG. Contemporary diagnosis and manage-ment of renal angiomyolipoma. J Urol 2002; 168(4 Pt 1): 1315−25.

Koh KB, George J. Radiological parameters of bleeding renal an-giomyolipoma. Scand J Urol Nephrol 1996; 30(4): 265−8.

Chen SS, Lin AT, Chen KK, Chang LS. Renal angiomyolipoma: experience of 20 years in Taiwan. Eur Urol 1997; 32(2): 175−8.

Lemaitre L, Robert Y, Dubrulle F, Claudon M, Duhamel A, Danjou P, et al. Renal angiomyolipoma: growth followed up with CT and/or US. Radiology 1995; 197(3): 598−602.

Rao PN, Osborn DE, Barnard RJ, Best JJ. Symptomatic renal an-giomyolipoma. Br J Urol 1981; 53(3): 212−5.

Koike H, Müller SC, Hohenfellner R. Management of renal angi-omyolipoma: a report of 14 cases and review of the literature. Is nonsurgical treatment adequate for this tumor. Eur Urol 1994; 25(3): 183−8.

Fujii Y, Ajima J, Oka K, Tosaka A, Takehara Y. Benign renal tumors detected among healthy adults by abdominal ultraso-nography. Eur Urol 1995; 27(2): 124−7.

Hajdu SI, Foote FW. Angiomyolipoma of the kidney: report of 27 cases and review of the literature. J Urol 1969; 102(4): 396−401.

Skolarus TA, Serrano MF, Berger DA, Bullock TL, Yan Y, Humph-rey PA, et al. The distribution of histological subtypes of renal tumors by decade of life using the 2004 WHO classification. J Urol 2008; 179(2): 439−43.

Blute ML, Malek RS, Segura JW. Angiomyolipoma: clinical me-tamorphosis and concerns. J Urol 1988; 139(1): 20−4.

Berglund RK, Bernstein M, Manion MT, Touijer KA, Russo P. Inci-dental angiomyolipoma resected during renal surgery for an enhancing renal mass. BJU Int 2009; 104(11): 1650−4.

Simmons JL, Hussain SA, Riley P, Wallace DM. Management of renal angimyolipoma in poatients with tuberous sclerosis com-plex. Oncol Rep 2003; 10(1): 237−41.

Zhang JQ, Fielding JR, Zou KH. Etiology of spontaneous perirenal hemorrhage: a meta-analysis. J Urol 2002; 167(4): 1593−6.

Mongha R, Bansal P, Dutta A, Das RK, Kundu AK. Wunderlich's syndrome with hepatic angiomyolipoma in tuberous sclerosis. Indian J Cancer 2008; 45(2): 64−6.

Dickinson M, Ruckle H, Beaghler M, Hadley HR. Renal angiomyo-lipoma: optimal treatmeni based on size and symptoms. Clin Nephrol 1998; 49(5): 281−6.

Kato I, Inayama Y, Yamanaka S, Ohshiro H, Gomi K, Shirai S, et al. Epithelioid angiomyolipoma of the kidney. Pathol Int 2009; 59(1): 38−43.

Makhlouf HR, Remotti HE, Ishak KG. Expression of KIT (CD117) in Angiomyolipoma. Am J Surg Pathol 2002; 26(4): 493−7.

Mete O, Kwast TH. Epithelioid angiomyolipoma: a morphologi-cally distinct variant that mimics a variety of intra-abdominal neoplasms. Arch Pathol Lab Med 2011; 135(5): 665−70.

Faraji H, Nguyen BN, Mai KT. Renal epithelioid angiomyoli-poma: a study of six cases and a meta-analytic study. Devel-opment of criteria for screening the entity with prognostic sig-nificance. Histopathology 2009; 55(5): 525−34.

Chan SY, Chan WK. Huge renal angiomyolipomas in tuberous sclerosis complex. Nephrology 2005; 10(4): 382−6.

Sooriakumaran P, Gibbs P, Coughlin G, Attard V, Elmslie F, Kingswood C, et al. Angiomyolipomata: challenges, solutions, and future prospects based on over 100 cases treated. BJU Int 2010; 105(1): 101−6.

Morelli L, Pusiol T, Piscioli I, Larosa M, Pozzoli GL, Monica B. Concurrent occurrence of three primary neoplasms with dif-ferent hystotype in the same kidney, associated with an ade-noma of the omolateral adrenal gland: first case report. Int J Urol 2006; 13(9): 1236−9.

Linder B, Hong Y, Jarrett T. Intra-renal adrenal adenoma: a compelling addition to the differential diagnosis of renal mass. Int J Urol 2009; 16(11): 912−4.

Objavljeno
2015/04/23
Broj časopisa
Vol. 71 Br. 4 (2014)
Rubrika
Prikaz bolesnika